Loading data
Company
WUXI BIO
02269HKEX
| Unit: CNY | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 21.79 bn CNY | 18.68 bn CNY | 17.03 bn CNY | 15.27 bn CNY | 10.29 bn CNY |
| Cost of revenue | 10.32 bn CNY | 9.59 bn CNY | 9.04 bn CNY | 7.74 bn CNY | 4.98 bn CNY |
| Research and development expense | 860.13 m CNY | 773.2 m CNY | 792.58 m CNY | 689.57 m CNY | 507.83 m CNY |
| Selling, general and administrative expense | 2.31 bn CNY | 2.15 bn CNY | 1.79 bn CNY | 1.43 bn CNY | 1 bn CNY |
| Operating profit after depreciation | 6.65 bn CNY | 4.59 bn CNY | 3.93 bn CNY | 4.35 bn CNY | 3.17 bn CNY |
| Operating profit before depreciation | 8.09 bn CNY | 6.02 bn CNY | 5.1 bn CNY | 5.15 bn CNY | 3.65 bn CNY |
| EBIT | 6.65 bn CNY | 4.59 bn CNY | 3.93 bn CNY | 4.35 bn CNY | 3.17 bn CNY |
| EBITDA | 8.09 bn CNY | 6.02 bn CNY | 5.1 bn CNY | 5.15 bn CNY | 3.65 bn CNY |
| Interest expense | 158.14 m CNY | 213.45 m CNY | 232.2 m CNY | 124.18 m CNY | 103.23 m CNY |
| Profit before tax | 7.26 bn CNY | 4.83 bn CNY | 4.17 bn CNY | 5.36 bn CNY | 3.99 bn CNY |
| Income tax expense | 1.52 bn CNY | 889.03 m CNY | 603.18 m CNY | 807.87 m CNY | 484.54 m CNY |
| Income before extraordinary items | 4.91 bn CNY | 3.36 bn CNY | 3.4 bn CNY | 4.42 bn CNY | 3.39 bn CNY |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.